![](/img/cover-not-exists.png)
Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans
Ben-Joseph, Rami, Chen, Chi-Chang, De, Ajita P., Wade, Rolin L., Shah, DhvaniVolume:
17
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696998.2014.925464
Date:
October, 2014
File:
PDF, 549 KB
english, 2014